Cite
HARVARD Citation
Gamucci, T. et al. (2019). A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study. Cancer biology & therapy. 20 (2), pp. 192-200. [Online].